The final four months of the year is traditionally a busy time for new listings in Asia and, with September less than two weeks away, market participants are watching for a potential revival of the IPO market.
With the exception of a couple of high-profile deals in Malaysia, there have been few reasons for excitement so far this year and, in mid-July, just after Malaysia’s IHH Healthcare had completed its $2.1 billion IPO, the value of new listings in Asia ex-Japan was down 51% from the same period last year, according to Dealogic data.
Global stock markets have been grinding upwards during the past few weeks,...